Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: results of a randomized, double-blind, double-dummy, controlled clinical trial
Open Access
- 1 January 2003
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 38 (1) , 51-58
- https://doi.org/10.1016/s0168-8278(02)00350-1
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Non‐absorbable antibiotics for managing intestinal gas production and gas‐related symptomsAlimentary Pharmacology & Therapeutics, 2000
- Evaluation of the efficacy and safety of rifaximin in the treatment of hepatic encephalopathyEuropean Journal of Gastroenterology & Hepatology, 2000
- Complications of cirrhosis III. Hepatic encephalopathyJournal of Hepatology, 2000
- Treatment of Hepatic EncephalopathyNew England Journal of Medicine, 1997
- RifaximinDrugs, 1995
- Rifaximin in the treatment of chronic hepatic encephalopathyCurrent Medical Research and Opinion, 1995
- The treatment of major complications of cirrhosisAlimentary Pharmacology & Therapeutics, 1994
- Antimicrobial activity and spectrum of rifaximin, a new topical rifamycin derivativeDiagnostic Microbiology and Infectious Disease, 1993
- Double-blind, double-dummy comparison between treatment andwith rifaximin and lactulose in patients with medium to severe patients with medium to severeCurrent Medical Research and Opinion, 1993
- Ammonia: Key factor in the pathogenesis of hepatic encephalopathyNeurochemical Pathology, 1987